Senior insider sale
Chief Scientific Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$10.18M
502.40K shares
ROBINS HARLAN S plans to sell 502.40K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $10.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
Acquired as compensation -- Restricted Stock Units
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Acquired as compensation -- Performance Awards Compensation | 13.46K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 3.56K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 18.27K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 7.21K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 6.21K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 30.43K | — |
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 22.54K | — |
3/4/2024 | Acquired as compensation -- Restricted Stock Units Compensation | 48.05K | — |
3/6/2023 | Acquired as compensation -- Restricted Stock Units Compensation | 55.77K | — |
3/6/2023 | Acquired as compensation -- Restricted Stock Units Compensation | 46.02K | — |
3/4/2022 | Acquired as compensation -- Restricted Stock Units Compensation | 61.78K | — |
3/4/2022 | Acquired as compensation -- Restricted Stock Units Compensation | 44.23K | — |
3/4/2021 | Acquired as compensation -- Restricted Stock Units Compensation | 17.17K | — |
3/4/2021 | Acquired as compensation -- Restricted Stock Units Compensation | 11.55K | — |
| Total | 386.24K | ||
Completed
Units to sell
6.16K
Market value
$110.9K
Units to sell
100K
Market value
$1.74M
Units to sell
10K
Market value
$148.3K
Planned — Approximate Date
Units to sell
386.24K
Market value
$8.18M
Units
502.40K
Value
$10.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2026 | 6.16K | $110.9K | — | Completed |
6/15/2026 | 100K | $1.74M | — | Completed |
4/8/2026 | 10K | $148.3K | — | Completed |
| Planned — Approximate Date | ||||
7/2/2026 | 386.24K | $8.18M | NASD | Planned |
| Total | 502.40K | $10.18M | ||